Biomega Group (‘Biomega’), a leading biosciences company producing high-quality and sustainable salmon ingredients for the human and pet health sectors, has announced the appointment of Espen Aarstad as its new Chief Financial Officer.

Aarstad, who has been working as the company’s interim CFO since last Autumn, will now move into the role in an official capacity on 1st March 2021. He joins Biomega following a 20-year career in finance, where he held multiple positions in leading manufacturing companies, including Group CFO at Totaltek AS in Oslo and Protan AS in Norway.

“It is a pleasure to join the Biomega team, particularly as the company accelerates its 2021 strategic plans,” Aarstad commented. “Biomega has seen rapid growth in the past couple of years and I’m truly excited to be involved in such an ambitious investment strategy. This year will see the Biomega brand achieve new heights in performance as we investigate the numerous health opportunities for human grade salmon ingredients.”

The news of Aarstad’s appointment completes the Norwegian-based company’s leadership team and follows the announcement of Stig Victor Petersen as CEO last October. Aarstad will take a pivotal position in the company as Biomega continues to invest in its proprietary R&D technology as part of an ambitious expansion strategy, exploring upcoming opportunities in the human nutrition market.

Petersen added: “Since Espen stepped in as interim CFO last year, he has provided the leadership team with accelerated business insight based on a wealth of knowledge obtained through previous positions. His strong financial capabilities, combined with a passion for biotechnology and manufacturing, will provide us with great direction as we move further into 2021. We are pleased to welcome Espen in an official capacity to our team.”

The company’s current strategy remains unchanged, with continued focus on advancing biotechnology to release the full nutritional and functional value of underutilised side streams in the salmon industry.

For more information on Biomega and its activities, please visit